Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
16.00
-5.55 (-25.75%)
At close: Mar 9, 2026, 4:00 PM EDT
16.25
+0.25 (1.56%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Olema Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,259 | 430 | 766 | 98 | 372 | 1,840 | |
| Market Cap Growth | 233.88% | -43.88% | 679.84% | -73.58% | -79.78% | - | |
| Enterprise Value | 934 | 217 | 492 | -122 | 66 | 1,861 | |
| Last Close Price | 16.00 | 5.83 | 14.03 | 2.45 | 9.36 | 48.08 | |
| PB Ratio | 3.57 | 1.05 | 3.02 | 0.50 | 1.31 | 5.44 | |
| P/TBV Ratio | 4.09 | 1.05 | 3.02 | 0.50 | 1.31 | 5.44 | |
| Debt / Equity Ratio | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | - | |
| Net Debt / Equity Ratio | -1.05 | -1.06 | -1.02 | -1.02 | -1.00 | -1.00 | |
| Net Debt / EBITDA Ratio | 2.03 | 3.05 | 2.48 | 1.89 | 3.98 | 15.73 | |
| Net Debt / FCF Ratio | 2.41 | 4.14 | 3.10 | 2.45 | 5.43 | 16.99 | |
| Quick Ratio | 7.97 | 10.45 | 12.14 | 12.37 | 31.86 | 73.84 | |
| Current Ratio | 8.03 | 10.50 | 12.33 | 12.62 | 32.23 | 74.62 | |
| Return on Equity (ROE) | -59.23% | -39.06% | -42.82% | -43.47% | -22.83% | -13.13% | |
| Return on Assets (ROA) | -34.41% | -24.43% | -26.63% | -26.14% | -13.99% | -7.85% | |
| Return on Capital Employed (ROCE) | -51.60% | -34.80% | -41.10% | -53.70% | -24.90% | -6.40% | |
| Earnings Yield | -11.91% | -30.11% | -12.61% | -106.63% | -19.11% | -1.20% | |
| FCF Yield | -10.70% | -24.30% | -10.93% | -83.88% | -14.05% | -1.08% | |
| Buyback Yield / Dilution | -54.75% | -29.83% | -13.13% | -1.19% | -462.91% | -170.75% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.